发明名称 |
PEPTIDES DERIVED FROM HIV GP41 FOR TREATING T-CELL MEDIATED PATHOLOGIES |
摘要 |
The present invention provides peptides, derivatives and analogs comprising an amino acid sequence HTTWMEWD (SEQ ID NO: 1) derived from the ectodomain of HIV gp41 protein, pharmaceutical compositions comprising same, and uses thereof for therapy of T-cell mediated diseases and disorders. |
申请公布号 |
US2015175666(A1) |
申请公布日期 |
2015.06.25 |
申请号 |
US201314408950 |
申请日期 |
2013.06.25 |
申请人 |
Yeda Research and Development Co. Ltd. |
发明人 |
Shai Yechiel;Ashkenazi Avraham;Faingold Omri;Ben Nun Avraham;Kaushansky Nathali |
分类号 |
C07K14/005;A61K38/16;C12N7/00 |
主分类号 |
C07K14/005 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated peptide of 10-30 amino acids comprising the amino acid sequence WNHTTWMEWD as set forth in SEQ ID NO: 2, or an analog thereof comprising at least one D amino acid. |
地址 |
Rehovot IL |